Dren bio

Dren

This company develops therapeutic antibodies to treat patients with cancer and autoimmune diseases by selectively depleting disease-causing cells.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

Seranova Bio

This biotechnology company develops autoantibody-based therapeutics and discovery platforms for pharmaceutical partners and clinicians treating autoimmune diseases, cancer and neurodegenerative disorders.

Abalone Bio

This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.

Viridiantherapeutics

This company develops antibody treatments for patients living with rare autoimmune conditions and thyroid eye disease.

Granite Bio

This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.